UK government reveals £50M R&D fund as it attempts to assuage drugmakers’ concerns news2025-09-25T13:59:06+00:00September 25th, 2025|Endpoints News|
Merck KGaA CEO Belén Garijo to leave next May, when electronics unit leader will take the helmnews2025-09-25T11:25:21+00:00September 25th, 2025|Endpoints News|
AstraZeneca files to try to bring IRA fight to Supreme Court news2025-09-24T19:25:34+00:00September 24th, 2025|Endpoints News|
Arcturus sues AbbVie over Capstan-related trade secrets claimnews2025-09-24T18:43:11+00:00September 24th, 2025|Endpoints News|
Harmony Biosciences’ cannabidiol drug fails Phase 3 trial in fragile Xnews2025-09-24T13:31:24+00:00September 24th, 2025|Endpoints News|
Biogen gets ‘unexpected’ CRL for high-dose Spinraza, will submit more technical datanews2025-09-24T11:08:55+00:00September 24th, 2025|Endpoints News|
Gates, Clinton orgs team up with Indian manufacturers to make $40 generic of Gilead’s twice-yearly PrEP drugnews2025-09-24T11:00:26+00:00September 24th, 2025|Endpoints News|
Sanofi adds $625M to its corporate venture armnews2025-09-24T05:00:16+00:00September 24th, 2025|Endpoints News|
Aera Therapeutics jumps into in vivo CAR-T race with trial planned for 2026news2025-09-23T18:00:33+00:00September 23rd, 2025|Endpoints News|
Lilly sets aside $6.5B for new Texas site to make its obesity pill news2025-09-23T17:00:55+00:00September 23rd, 2025|Endpoints News|
